WikiPathways:NewPathwayReleases

From WikiPathways

(Difference between revisions)
Jump to: navigation, search
(back filled to 2017)
Line 117: Line 117:
|}
|}
-
===December 2019===
+
=== Prior Years ===
-
{| style="margin: 10px; background-color:#E4EEF2"
+
* [WikiPathways:NewPathwayReleases2019|2019]
-
|width=100px|{{#pwImage:Pathway:WP4685|250px||Melanoma (Homo sapiens)}}
+
-
|width=100px|{{#pwImage:Pathway:WP4751|250px||HIPK2 in kidney fibrosis (Homo sapiens)}}
+
-
|width=100px|{{#pwImage:Pathway:WP4758|250px||Nephrotic syndrome (Homo sapiens)}}
+
-
|}
+
-
 
+
-
===November 2019===
+
-
 
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP506|250px||Fatty Acid Beta Oxidation (Rattus norvegicus)}}
+
-
|width=100px|{{#pwImage:Pathway:WP376|250px||Renin - Angiotensin System (Rattus norvegicus)}}
+
-
|width=100px|{{#pwImage:Pathway:WP4722|250px||Glycerolipids and Glycerophospholipids (Homo sapiens)}}
+
-
|width=100px|{{#pwImage:Pathway:WP4724|250px||Omega-9 FA synthesis (Homo sapiens)}}
+
-
|-
+
-
|width=100px|{{#pwImage:Pathway:WP4726|250px||Sphingolipid Metabolism (integrated pathway) (Homo sapiens)}}
+
-
|width=100px|{{#pwImage:Pathway:WP4585|250px||Overview of interferons-mediated signaling pathway (Homo sapiens)}}
+
-
|width=100px|{{#pwimage:Pathway:WP4723|250px||Omega-3/Omega-6 FA synthesis (Homo sapiens)}}
+
-
|width=100px|{{#pwImage:Pathway:WP4483|250px||Relationship between inflammation, COX-2 and EGFR (Homo sapiens)}}
+
-
|-
+
-
|width=100px|{{#pwimage:Pathway:WP4720|250px||Eicosanoid metabolism via Cytochrome P450 Mono-Oxygenases (CYP) pathway (Homo sapiens)}}
+
-
|width=100px|{{#pwImage:Pathway:WP4742|250px||Ketogenesis and Ketolysis (Homo sapiens)}}
+
-
|width=100px|{{#pwImage:Pathway:WP4719|250px||Eicosanoid metabolism via Cyclo Oxygenases (COX) (Homo sapiens)}}
+
-
|width=100px|{{#pwImage:Pathway:WP4718|250px||Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) (Homo sapiens)}}
+
-
|-
+
-
|width=100px|{{#pwImage:Pathway:WP4674|250px||Head and Neck Squamous Cell Carcinoma (Homo sapiens)}}
+
-
|width=100px|{{#pwImage:Pathway:WP4721|250px||Eicosanoid metabolism via Lipo Oxygenases (LOX) (Homo sapiens)}}
+
-
|width=100px|{{#pwImage:Pathway:WP4725|250px||Sphingolipid Metabolism (general overview) (Homo sapiens)}}
+
-
|}
+
-
=== 201910 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP4629|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4705|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4673|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4659|250px||}}
+
-
|}
+
-
=== 201909 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP4690|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4351|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4350|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4345|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4344|250px||}}
+
-
|}
+
-
=== 201908 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP4598|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4597|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4666|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4661|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4658|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4627|250px||}}
+
-
|}
+
-
=== 201907 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP264|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4542|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4577|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4657|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4549|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4656|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4655|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4584|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4583|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4586|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4589|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4183|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP2375|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP2079|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP27|250px||}}
+
-
|}
+
-
=== 201906 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP4156|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4538|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4582|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4585|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4595|250px||}}
+
-
|}
+
-
=== 201905 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP4562|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4561|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4571|250px||}}
+
-
|}
+
-
=== 201904 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP4478|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4559|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4565|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4484|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4564|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4553|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4566|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4560|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4535|250px||}}
+
-
|}
+
-
=== 201903 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP4493|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4522|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4524|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4545|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4495|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4494|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4389|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4496|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4519|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4518|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4521|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4523|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4537|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4539|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4541|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4533|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4536|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4532|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4534|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4540|250px||}}
+
-
|}
+
-
=== 201902 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP4292|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4504|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4507|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4506|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4349|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4348|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4347|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4346|250px||}}
+
-
|}
+
-
=== 201901 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP2813|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP2817|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4331|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4479|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP2815|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP2814|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP1495|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4481|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4321|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4480|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4312|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4482|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4335|250px||}}
+
-
|}
+
-
=== 201812 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP4217|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4352|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4462|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4474|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP1963|250px||}}
+
-
|}
+
-
=== 201811 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP4400|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4399|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4397|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4271|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4396|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4398|250px||}}
+
-
|}
+
-
=== 201810 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP4341|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4342|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4357|250px||}}
+
-
|}
+
-
=== 201809 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP4329|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4337|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4336|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4225|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4236|250px||}}
+
-
|}
+
-
=== 201808 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP4269|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4299|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4320|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4298|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4324|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4268|250px||}}
+
-
|}
+
-
=== 201807 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP3591|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4312|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4313|250px||}}
+
-
|}
+
-
=== 201806 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP2882|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP3299|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP3666|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP2640|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4300|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4301|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4290|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4292|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4189|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4288|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4286|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4297|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4304|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4259|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4265|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP3654|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP2940|250px||}}
+
-
|}
+
-
=== 201805 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP4018|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP2840|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP2806|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4217|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP3963|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4249|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4258|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4263|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4255|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4262|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4222|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4225|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4228|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4241|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4284|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP1486|250px||}}
+
-
|}
+
-
=== 201804 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP4232|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4231|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4223|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4224|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4233|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4239|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4240|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4229|250px||}}
+
-
|}
+
-
=== 201803 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP2203|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP1449|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP2023|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4216|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4220|250px||}}
+
-
|}
+
-
=== 201802 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP4141|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4204|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4172|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4197|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4205|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4206|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4210|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4211|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4173|250px||}}
+
-
|}
+
-
=== 201801 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP2456|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP2645|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4174|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4186|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4191|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4136|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4194|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP563|250px||}}
+
-
|}
+
-
=== 201711 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP4159|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4156|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP3869|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP2826|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP3965|250px||}}
+
-
|}
+
-
=== 201710 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP3580|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP2457|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP2876|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4155|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4153|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP2877|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP2074|250px||}}
+
-
|}
+
-
=== 201709 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP4020|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4021|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4149|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4022|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP3982|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4030|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4142|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4016|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4147|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4144|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP3981|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4150|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4148|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4146|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP4145|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP398|250px||}}
+
-
|}
+
-
=== 201708 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP4008|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP3998|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP3995|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP3996|250px||}}
+
-
|}
+
-
=== 201707 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP2634|250px||}}
+
-
|}
+
-
=== 201706 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP3992|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP3979|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP3991|250px||}}
+
-
|}
+
-
=== 201705 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|}
+
-
=== 201704 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP3962|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP3971|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP1541|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP3972|250px||}}
+
-
|}
+
-
=== 201703 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP3967|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP3969|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP3968|250px||}}
+
-
|}
+
-
=== 201702 ===
+
-
{| style="margin: 10px; background-color:#E4EEF2"
+
-
|width=100px|{{#pwImage:Pathway:WP3888|250px||}}
+
-
|width=100px|{{#pwImage:Pathway:WP3959|250px||}}
+
-
|}
+

Revision as of 02:51, 4 September 2020

Each month there are new pathways reviewed and approved for the official release of WikiPathways. See the Download Page to access the full collection.

Contents

August 2020

Image does not exist
Beta Oxidation of Unsaturated Fatty Acids (Caenorhabditis elegans)

July 2020

Image does not exist
MAPK pathway in congenital thyroid cancer (Homo sapiens)
Image does not exist
15q11.2 copy number variation syndrome (Homo sapiens)
Image does not exist
Mitochondrial Complex I inhibition leading to chemical induced fanconi syndrome (Homo sapiens)
Image does not exist
NO metabolism in cystic fibrosis (Homo sapiens)

June 2020

Image does not exist
EGFR Tyrosine Kinase Inhibitor Resistance (Homo sapiens)
Image does not exist
The influence of laminopathies on Wnt signaling (Homo sapiens)
Image does not exist
Linoleic acid metabolism known to be affected by coronavirus infection (Homo sapiens)
Image does not exist
Endoplasmic reticulum (ER) stress response in Coronavirus infection (Homo sapiens)
Image does not exist
SARS-CoV-2 and Angiotensin-converting enzyme 2 (ACE2) receptor: Molecular mechanisms and potential therapeutic target (Homo sapiens)
Image does not exist
LDLRAD4 and what we know about it (Homo sapiens)
Image does not exist
3q29 copy number variation syndrome (Homo sapiens)
Image does not exist
COVID-19, thrombosis and anticoagulation (Homo sapiens)
Image does not exist
Direct Reversal Repair (Homo sapiens)

May 2020

Image does not exist
Mitochondrial CIV Assembly (Homo sapiens)
Image does not exist
Autophagy (Homo sapiens)
Image does not exist
Unfolded protein response (Homo sapiens)
Image does not exist
MAP3K1 role in promoting and blocking gonadal determination (Homo sapiens)
Image does not exist
Cellular Proteostasis (Homo sapiens)
Image does not exist
Neuroinflammation (Homo sapiens)
Image does not exist
Mitochondrial CII Assembly (Homo sapiens)
Image does not exist
Mitochondrial CIII assembly (Homo sapiens)
Image does not exist
Purinergic signaling (Homo sapiens)
Image does not exist
1q21.1 copy number variation syndrome (Homo sapiens)
Image does not exist
SARS coronavirus and innate immunity (Homo sapiens)
Image does not exist
Proximal tubule transport (Homo sapiens)
Image does not exist
Somatic Sex determination (Homo sapiens)
Image does not exist
Peroxiredoxin 2 induced ovarian failure (Homo sapiens)
Image does not exist
Disruption of postsynaptic signalling by CNV (Homo sapiens)
Image does not exist
Interacting Laminopathic Pathways (Homo sapiens)
Image does not exist
Peroxiredoxin 2 induced ovarian failure (Mus musculus)
Image does not exist
Mammalian disorder of sexual development (Homo sapiens)

April 2020

Image does not exist
Nanomaterial-induced Inflammasome Activation (Homo sapiens)
Image does not exist
Oxidative Stress and Redox Pathway (Mus musculus)
Image does not exist
Downregulation of ACE2 expression by SARS-CoV infection and SARS-CoV Spike protein. (Homo sapiens)
Image does not exist
Ciliopathies (Homo sapiens))
Image does not exist
Cholesterol Biosynthesis with Skeletal Dysplasias (Homo sapiens)
Image does not exist
Endochondral Ossification with Skeletal Dysplasias (Homo sapiens)
Image does not exist
Glycosaminoglycan degradation (Homo sapiens)
Image does not exist
Conversion of Angiotensinogen to Angiotensin II (Homo sapiens)
Image does not exist
GDNF/RET signalling axis (Mus musculus)
Image does not exist
Genes controlling renal nephrogenesis (Homo sapiens)
Image does not exist
Regucalcin in proximal tubule epithelial kidney cells (Homo sapiens)
Image does not exist
COVID-19 AOP (Homo sapiens)
Image does not exist
Intracellular trafficking proteins involved in CMT neuropathy (Homo sapiens)
Image does not exist
Hijack of Ubiquitination by SARS-CoV-2 (Homo sapiens)
Image does not exist
Host-pathogen interaction of human corona viruses - autophagy (Homo sapiens)
Image does not exist
Host-pathogen interaction of human corona viruses - apoptosis (Homo sapiens)
Image does not exist
Type I Interferon Induction and Signaling During SARS-CoV-2 Infection (Homo sapiens)
Image does not exist
Kisspeptin/Kisspeptin Receptor System in the Ovary (Homo sapiens)
Image does not exist
Activation of NLRP3 Inflammasome by SARS-CoV-2 (Homo sapiens)
Image does not exist
Pathogenesis of SARS-CoV-2 Mediated by nsp9/nsp10 Complex (Homo sapiens)
Image does not exist
Host-pathogen interaction of human corona viruses - MAPK signaling (Homo sapiens)
Image does not exist
Host-pathogen interaction of human corona viruses - Interferon induction (Homo sapiens)

March 2020

Image does not exist
Proteoglycan biosynthesis (Homo sapiens)
Image does not exist
Somitogenesis in the context of spondylocostal dysostosis (Homo sapiens)
Image does not exist
Type I collagen synthesis in the context of Osteogenesis imperfecta (Homo sapiens)
Image does not exist
Osteoblast differentiation (Homo sapiens)
Image does not exist
Autosomal recessive Osteopetrosis pathways (Homo sapiens)
Image does not exist
MED and Pseudoachondroplasia genes (Homo sapiens)
Image does not exist
FGF23 signalling in Hypophosphatemic rickets (Homo sapiens)
Image does not exist
mBDNF and proBDNF regulation of GABA neurotransmission (Homo sapiens)
Image does not exist
GDNF/RET signalling axis (Homo sapiens)

February 2020

Image does not exist
FGFR3 signalling in chondrocyte proliferation and terminal differentiation (Homo sapiens)
Image does not exist
Purine metabolism (Homo sapiens)
Image does not exist
Monoterpene Biosynthesis Pathway Genes in Mint (Homo sapiens)

January 2020

Image does not exist
Vitamin D-sensitive calcium signaling in depression (Homo sapiens)
Image does not exist
Thyroid hormones production and their peripheral downstream signalling effects regarding congenital hypothyroidism (Homo sapiens)
Image does not exist
Netrin-UNC5B signaling Pathway (Homo sapiens)
Image does not exist
Base Excision Repair (Homo sapiens)
Image does not exist
Nucleotide Excision Repair (Homo sapiens)
Image does not exist
IL-18 signaling pathway (Homo sapiens)
Image does not exist
Renin Angiotensin Aldosterone System (RAAS) (Homo sapiens)
Image does not exist
PKC-gamma calcium signaling pathway in ataxia (Homo sapiens)
Image does not exist
Regulation of Pgc1a expression by a Gsk3b-Tfeb signaling axis in skeletal muscle (Mus musculus)

Prior Years 

* [WikiPathways:NewPathwayReleases2019|2019]
Retrieved from "https://classic.wikipathways.org/index.php/WikiPathways:NewPathwayReleases"
Personal tools